NCT06175312View on ClinicalTrials.gov

Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1)

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 25, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Basic Science: Visual Attention in Healthy ParticipantsBasic Science: Neural Representations of LocationAttention
Interventions
OTHER

Stimulus properties: salience-defining feature

The feature used to define a salient location will be varied across trials (checkerboard contrast; motion direction; color hue)

OTHER

Stimulus properties: magnitude of salience

The magnitude of the salient location will be varied across trials independently from salience-defining feature (based on feature contrast)

Trial Locations (1)

93117

University of California, Santa Barbara, Santa Barbara

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

University of California, Santa Barbara

OTHER

NCT06175312 - Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1) | Biotech Hunter | Biotech Hunter